Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Applied Dna Scns (NQ: APDN ) 1.990 -0.040 (-1.97%) Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Applied Dna Scns < Previous 1 2 3 4 Next > Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML May 13, 2024 Via ACCESSWIRE Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results May 10, 2024 Via ACCESSWIRE Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement May 10, 2024 Via ACCESSWIRE Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program April 25, 2024 Via ACCESSWIRE Applied DNA Announces 1-For-20 Reverse Stock Split April 22, 2024 Via ACCESSWIRE Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results February 08, 2024 Via ACCESSWIRE Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results December 07, 2023 Via ACCESSWIRE Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA) November 16, 2023 Via ACCESSWIRE The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover April 09, 2024 Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI. Via MarketBeat Topics Cannabis Exposures Cannabis Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start March 18, 2024 Via ACCESSWIRE Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress March 14, 2024 Via ACCESSWIRE Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 February 05, 2024 Via ACCESSWIRE Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules February 02, 2024 Via ACCESSWIRE Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform November 09, 2023 Via ACCESSWIRE Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update August 10, 2023 Via ACCESSWIRE Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update May 11, 2023 Via ACCESSWIRE Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules January 31, 2024 Via ACCESSWIRE Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow December 14, 2023 Via ACCESSWIRE Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 December 05, 2023 Via ACCESSWIRE Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application November 28, 2023 Via ACCESSWIRE Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals September 14, 2023 Via ACCESSWIRE Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs September 06, 2023 Via ACCESSWIRE Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit August 29, 2023 Via ACCESSWIRE Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production August 23, 2023 Via ACCESSWIRE Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023 August 07, 2023 Via ACCESSWIRE Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences July 18, 2023 Via ACCESSWIRE Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach July 13, 2023 Via ACCESSWIRE Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference June 08, 2023 Via ACCESSWIRE Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023 May 03, 2023 From Applied DNA Sciences, Inc. Via Business Wire Applied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal Regulation April 07, 2023 From Applied DNA Sciences, Inc. Via Business Wire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.